Patents by Inventor Jean-Pierre Lablanchy

Jean-Pierre Lablanchy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190314287
    Abstract: A method for packaging a lipid compound for ingestion by a human or animal body, comprising the following steps: filling (I) a first part of a prefabricated capsule, previously opened in two parts, with a predetermined volume of a lipid compound; introducing (II) a food-grade lipophilic absorbent into the lipid compound (4) within this first part, so as to produce, after absorption of the lipid compound, a core in the form of a pasty mixture providing for a predetermined dissolution rate, closing (III) the capsule by fitting the second part on the first part containing the core; and coating the capsule thus closed with a polymer, so as to allow subsequent release of the lipid compound at a predetermined release site within said human or animal body.
    Type: Application
    Filed: December 21, 2017
    Publication date: October 17, 2019
    Inventors: Bernard Jacques Kurdyk, Jean-Pierre Lablanchy
  • Publication number: 20080299150
    Abstract: A method for processing immuno-competent cells in view of an antiviral therapy on a human or animal subject, includes: a step for collecting immuno-competent cells on the human or animal subject, and a step for processing the collected immuno-competent cells, so as to stimulate at least a part of the immuno-competent cells, by presenting a muted viral particle to the cells, in view of a reinjection of the stimulated cells into the human or animal subject.
    Type: Application
    Filed: May 2, 2008
    Publication date: December 4, 2008
    Applicant: SANKHIA CORPORATION
    Inventors: Patrick Rambaud, Jean-Pierre Lablanchy
  • Publication number: 20020160051
    Abstract: A homeopathic medicine which includes at least biocompatible mother-of-pearl bio-aragonite. The medicine is used for treating pain of bone origin and in particular related to bone diseases cause by a pathology, pre-menopause or post-menopause estrogenic deficiency, ageing, cancer or trauma and to cartilaginous disorders, particularly osteoarthritis.
    Type: Application
    Filed: February 26, 2001
    Publication date: October 31, 2002
    Inventor: Jean-Pierre Lablanchy